Cargando…
A New Family of Jumonji C Domain-Containing KDM Inhibitors Inspired by Natural Product Purpurogallin
Aberrant epigenetic modifications are involved in cancer development. Jumonji C domain-containing histone lysine demethylases (KDMs) are found mainly up-regulated in breast, prostate, and colon cancer. Currently, growing interest is focusing on the identification and development of new inhibitors ab...
Autores principales: | Souto, José A., Sarno, Federica, Nebbioso, Angela, Papulino, Chiara, Álvarez, Rosana, Lombino, Jessica, Perricone, Ugo, Padova, Alessandro, Altucci, Lucia, de Lera, Ángel R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7261929/ https://www.ncbi.nlm.nih.gov/pubmed/32523934 http://dx.doi.org/10.3389/fchem.2020.00312 |
Ejemplares similares
-
3-Chloro-N′-(2-hydroxybenzylidene) benzohydrazide: An LSD1-Selective Inhibitor and Iron-Chelating Agent for Anticancer Therapy
por: Sarno, Federica, et al.
Publicado: (2018) -
Antiplatelet and antithrombotic activities of purpurogallin in vitro and in vivo
por: Ku, Sae-Kwang, et al.
Publicado: (2014) -
Molecular architecture of the Jumonji C family histone demethylase KDM5B
por: Dorosz, Jerzy, et al.
Publicado: (2019) -
KDM4 Involvement in Breast Cancer and Possible Therapeutic Approaches
por: Varghese, Benluvankar, et al.
Publicado: (2021) -
DOT1L: a key target in normal chromatin remodelling and in mixed-lineage leukaemia treatment
por: Sarno, Federica, et al.
Publicado: (2019)